Department of Emergency Medicine, University of California, San Francisco School of Medicine, San Francisco, CA.
Department of Emergency Medicine, University of California, San Francisco School of Medicine, San Francisco, CA.
Ann Emerg Med. 2021 Jul;78(1):35-43.e2. doi: 10.1016/j.annemergmed.2021.01.028. Epub 2021 Feb 5.
Among a comprehensive range of frontline emergency department health care personnel, we assessed symptoms of anxiety and burnout, specific coronavirus disease 2019 (COVID-19) work-related stressors, and risk for post-traumatic stress disorder (PTSD). We also determined whether COVID-19 serologic testing of HCP decreased their self-reported anxiety.
In a prospective cohort study from May 13, 2020, to July 8, 2020, we used electronic surveys to capture participant self-reported symptoms before and after serologic testing for anti-SARS-CoV-2 immunoglobulin G antibodies. Participants were physicians, nurses, advanced practice providers, and nonclinical ED personnel at 20 geographically diverse United States EDs. We evaluated these domains: 1) the effects of the COVID-19 pandemic on overall stress and anxiety; 2) COVID-19-related work stressors; 3) burnout; and 4) PTSD risk (measured using the Primary Care-PTSD Screen for DSM-5, a 5-item screening instrument in which a score of ≥3 signifies high risk for PTSD). We also assessed perceptions of whether results of COVID-19 antibody testing decreased participants' self-reported anxiety.
Of 1,606 participants, 100% and 88% responded to the baseline and follow-up surveys, respectively. At baseline, approximately half (46%) reported symptoms of emotional exhaustion and burnout from their work, and 308 (19.2%, 95% confidence interval [CI] 17.3% to 21.1%) respondents screened positive for increased PTSD risk. Female respondents were more likely than males to screen positive (odds ratio [OR] 2.03, 95% CI 1.49 to 2.78). Common concerns included exposing their family and the health of coworkers diagnosed with COVID-19. After receiving antibody test results, 54% (95% CI 51.8 to 56.7) somewhat agreed, agreed, or strongly agreed that knowledge of their immune status had decreased their anxiety. A positive serology result indicating prior SARS-CoV-2 infection was associated with a higher likelihood of reporting decreased anxiety (2.83, 95% CI 1.37 to 5.83).
Symptoms of anxiety and burnout were prevalent across the spectrum of ED staff during the COVID-19 pandemic. One-fifth of ED personnel appeared to be at risk for PTSD. Increased provision of serologic testing may help to mitigate anxiety.
在一系列全面的急诊一线医护人员中,我们评估了焦虑和倦怠症状、与新冠病毒病 2019(COVID-19)相关的特定工作压力源,以及创伤后应激障碍(PTSD)的风险。我们还确定了 COVID-19 血清学检测是否会降低医护人员的自我报告焦虑。
在 2020 年 5 月 13 日至 7 月 8 日进行的一项前瞻性队列研究中,我们使用电子调查在 COVID-19 血清 IgG 抗体检测前后采集参与者的自我报告症状。参与者是来自 20 个地理位置不同的美国急诊部的医生、护士、高级执业护士和非临床急诊人员。我们评估了以下领域:1)COVID-19 大流行对整体压力和焦虑的影响;2)与 COVID-19 相关的工作压力源;3)倦怠;4)PTSD 风险(使用用于 DSM-5 的主要医疗保健 PTSD 筛查量表进行评估,这是一种 5 项筛查工具,其中分数≥3 表示 PTSD 风险高)。我们还评估了 COVID-19 抗体检测结果是否降低了参与者自我报告焦虑的看法。
在 1606 名参与者中,分别有 100%和 88%的人对基线和随访调查做出了回应。在基线时,约有一半(46%)的人报告工作中出现情绪疲惫和倦怠的症状,308 人(19.2%,95%置信区间[CI]17.3%至 21.1%)筛查出 PTSD 风险增加。女性参与者比男性参与者更有可能筛查出阳性(优势比[OR]2.03,95%CI1.49 至 2.78)。常见的担忧包括暴露自己的家人和与 COVID-19 诊断的同事的健康。在收到抗体检测结果后,54%(95%CI51.8 至 56.7)的人表示或多或少同意、同意或强烈同意他们的免疫状态知识降低了他们的焦虑。血清学检测结果呈 SARS-CoV-2 既往感染阳性与报告焦虑减轻的可能性更高相关(2.83,95%CI1.37 至 5.83)。
在 COVID-19 大流行期间,急诊科工作人员普遍存在焦虑和倦怠症状。五分之一的急诊科人员似乎有 PTSD 风险。增加血清学检测的提供可能有助于减轻焦虑。